// App-Quantinova.ai

: Elective Vs Non-Elective Hospital Admissions By Patients with Multiple Myeloma in England 2014 - 2018

Researchers

Presenter

  • Karthik Ramasamy

Principal Investigators

  • Spyros Kolovos

  • Guido Nador

  • Rosemarie Finley

  • Matthew Streetly

  • Bhuvan Kishore

  • Neil K Rabin

  • Andrew D Chantry

  • Kwee Yong

  • John Ashcroft

  • Stella Bowcock

  • Mark T Drayson

  • Daniel Prieto-Alhambra

  • Cyrus Cooper

  • Muhammad Kassim Javaid

  • Rafael Pinedo-Villanueva

Medical Centers

  • Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

  • Department of Clinical Haematology, Oxford University Hospitals NHS Trust, Oxford ,

  • Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

  • Myeloma UK, Edinburgh, GBR

  • Guy's Hospital, Guy's & St. Thomas NHS Trust, London, United Kingdom

  • Heart of England NHS Foundation Trust, Birmingham, United Kingdom

  • Haematology, University College London Hospitals NHS Foundation Trust (UCLH), London, United Kingdom

  • Department of Histopathology, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, United Kingdom

  • Department of Oncology & Metabolism, University of Sheffield, Sheffield, United Kingdom

  • Bart's Cancer Institute, London, United Kingdom

  • Mid Yorkshire Hospitals NHS Trust, Wakefield, United Kingdom

  • Kings College London, London, United Kingdom

  • University of Birmingham, Birmingham, United Kingdom

  • Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom

  • Grup de Recerca en Malalties Prevalents de l'Aparell Locomotor Research Group and CIBERFes, University Institute for Primary CareResearch Jordi Gol, Universitat Autonoma de Barcelona and Instituto de Salud Carlos III, Barcelona, Spain

  • MRC Lifecourse Epidemiology Unit, University of South- ampton, Southampton, United Kingdom

  • NIHR Southampton Biomedi- cal Research Centre, University of Southampton and Univer- sity Hospital Southampton NHS Foundation Trust, South- ampton, Hampshire, UK

  • NIHR Oxford Biomedical Research Centre, Oxford University, Oxford, United Kingdom.

Locations

  • United Kingdom

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved